Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz-Josef Neumann

Showing results (281-290 of 477) with videos related to

Pageof 48
Sort By:
Frontiers in Cardiovascular Medicine|March 17, 2022
Machine Learning Using a Single-Lead ECG to Identify Patients With Atrial Fibrillation-Induced Heart FailureGiorgio Luongo, Felix Rees, Deborah Nairn, et al.
American Heart Journal|June 23, 2007
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trialJulinda Mehilli, Gjin Ndrepepa, Adnan Kastrati, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 18, 2014
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusionsHenning Kelbæk, Lene Holmvang, Gert Richardt, et al.
Circulation. Cardiovascular Interventions|July 25, 2013
Prognostic value of access and non-access sites bleeding after percutaneous coronary interventionGjin Ndrepepa, Franz-Josef Neumann, Gert Richardt, et al.
European Heart Journal|September 1, 2010
ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary interventionStefanie Schulz, Julinda Mehilli, Franz-Josef Neumann, et al.
Circulation|October 25, 2006
Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventionsGjin Ndrepepa, Adnan Kastrati, Julinda Mehilli, et al.
Journal of the American College of Cardiology|August 11, 2012
Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trialAljoscha Rastan, Klaus Brechtel, Hans Krankenberg, et al.
International Heart Journal|July 21, 2020
General Anesthesia or Conscious Sedation for Transfemoral Aortic Valve Replacement with the SAPIEN 3 Transcatheter Heart ValveFranz-Josef Neumann, Simon Redwood, Mohamed Abdel-Wahab, et al.
Journal of Clinical Medicine|November 14, 2023
Pre-Procedural Assessment of the Femoral Access Route for Transcatheter Aortic Valve Implantation: Comparison of a Non-Contrast Time-of-Flight Magnetic Resonance Angiography Protocol with Contrast-Enhanced Dual-Source Computed Tomography AngiographyJohannes Brado, Philipp Breitbart, Manuel Hein, et al.
American Heart Journal|March 5, 2004
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trialsDavid E Kandzari, Vic Hasselblad, James E Tcheng, et al.
Pageof 48

Showing results (281-290 of 477) with videos related to

Sort By:
Pageof 48
Frontiers in Cardiovascular Medicine|March 17, 2022
Machine Learning Using a Single-Lead ECG to Identify Patients With Atrial Fibrillation-Induced Heart FailureGiorgio Luongo, Felix Rees, Deborah Nairn, et al.
American Heart Journal|June 23, 2007
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trialJulinda Mehilli, Gjin Ndrepepa, Adnan Kastrati, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 18, 2014
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusionsHenning Kelbæk, Lene Holmvang, Gert Richardt, et al.
Circulation. Cardiovascular Interventions|July 25, 2013
Prognostic value of access and non-access sites bleeding after percutaneous coronary interventionGjin Ndrepepa, Franz-Josef Neumann, Gert Richardt, et al.
European Heart Journal|September 1, 2010
ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary interventionStefanie Schulz, Julinda Mehilli, Franz-Josef Neumann, et al.
Circulation|October 25, 2006
Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventionsGjin Ndrepepa, Adnan Kastrati, Julinda Mehilli, et al.
Journal of the American College of Cardiology|August 11, 2012
Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trialAljoscha Rastan, Klaus Brechtel, Hans Krankenberg, et al.
International Heart Journal|July 21, 2020
General Anesthesia or Conscious Sedation for Transfemoral Aortic Valve Replacement with the SAPIEN 3 Transcatheter Heart ValveFranz-Josef Neumann, Simon Redwood, Mohamed Abdel-Wahab, et al.
Journal of Clinical Medicine|November 14, 2023
Pre-Procedural Assessment of the Femoral Access Route for Transcatheter Aortic Valve Implantation: Comparison of a Non-Contrast Time-of-Flight Magnetic Resonance Angiography Protocol with Contrast-Enhanced Dual-Source Computed Tomography AngiographyJohannes Brado, Philipp Breitbart, Manuel Hein, et al.
American Heart Journal|March 5, 2004
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trialsDavid E Kandzari, Vic Hasselblad, James E Tcheng, et al.
Pageof 48